<qa>  What is the EFFECT OF RENAL IMPAIRMENT ON PHARMACOKEFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND TOLERABILITY OF ERTUGLIFLOZIN IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS MK-8835-009: 